• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UPF1缺陷会增强线粒体活性氧,从而促进胰腺导管腺癌中的免疫抑制微环境。

UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.

作者信息

Su Wenjuan, Kochen Rossi Juan, Nuevo-Tapioles Cristina, Chen Ting, Kawaler Emily, Branco Cristina, Wong Kwok-Kin, Simeone Diane M, Gardner Lawrence B, Philips Mark R

机构信息

Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY 10016.

Moores Cancer Center, University of California, San Diego, CA 92037.

出版信息

Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2401996121. doi: 10.1073/pnas.2401996121. Epub 2024 Aug 6.

DOI:10.1073/pnas.2401996121
PMID:40591563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11331118/
Abstract

Upstream frameshift 1 (UPF1) is an RNA helicase involved in a number of mRNA regulatory processes including nonsense-mediated decay. Mutations in the locus that reduce its expression have been associated with adenosquamous carcinoma of the pancreas, a particularly aggressive form of the disease. To determine the effect of suppression in a murine model of pancreatic adenocarcinoma, we silenced with shRNA in cells derived from an autochthonous tumor in an LSL-Kras; Trp53; Pdx-1 mouse (KPC) and orthotopically implanted these cells in the pancreas of C57BL/6 mice. Tumors derived from Upf1-deficient cells were markedly larger than those derived from control cells, a difference observed only in immunocompetent mice. The immune infiltrate of Upf1-deficient tumors was enriched in myeloid-derived suppressor cells (MDSCs) and depleted of CD8 cells compared to control KPC tumors. Upf1-deficient KPC cells secreted inflammatory cytokines including G-CSF and CXCL2, known to recruit MDSCs. Cytokine secretion from Upf1-deficient KPC cells was induced by increased levels of mitochondrial reactive oxygen species (ROS), which in turn were due to an increase in complex I activity in the electron transport chain. Thus, Upf1 helicase deficiency leads to increased mitochondrial complex I activity which produces ROS that signals for cytokine release that drives immune suppression and enhanced tumor growth.

摘要

上游移码蛋白1(UPF1)是一种RNA解旋酶,参与包括无义介导的衰变在内的多种mRNA调节过程。该基因座中降低其表达的突变与胰腺腺鳞癌相关,这是一种侵袭性特别强的疾病形式。为了确定在胰腺腺癌小鼠模型中抑制UPF1的作用,我们在源自LSL-Kras;Trp53;Pdx-1小鼠(KPC)的原位肿瘤细胞中用shRNA沉默UPF1,并将这些细胞原位植入C57BL/6小鼠的胰腺中。源自UPF1缺陷细胞的肿瘤明显大于源自对照细胞的肿瘤,这种差异仅在免疫健全的小鼠中观察到。与对照KPC肿瘤相比,UPF1缺陷肿瘤的免疫浸润富含髓源性抑制细胞(MDSC),而CD8细胞减少。UPF1缺陷的KPC细胞分泌包括G-CSF和CXCL2在内的炎性细胞因子,已知这些细胞因子可募集MDSC。UPF1缺陷的KPC细胞的细胞因子分泌是由线粒体活性氧(ROS)水平升高诱导的,而这又是由于电子传递链中复合物I活性增加所致。因此,UPF1解旋酶缺陷导致线粒体复合物I活性增加,产生ROS,发出细胞因子释放信号,从而驱动免疫抑制和肿瘤生长增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/de282a35dad2/pnas.2401996121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/b7164db7a1d5/pnas.2401996121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/985dfbe61b39/pnas.2401996121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/8b915fa0f11f/pnas.2401996121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/de282a35dad2/pnas.2401996121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/b7164db7a1d5/pnas.2401996121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/985dfbe61b39/pnas.2401996121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/8b915fa0f11f/pnas.2401996121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd98/11331118/de282a35dad2/pnas.2401996121fig04.jpg

相似文献

1
UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.UPF1缺陷会增强线粒体活性氧,从而促进胰腺导管腺癌中的免疫抑制微环境。
Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2401996121. doi: 10.1073/pnas.2401996121. Epub 2024 Aug 6.
2
Pancreatic STAT5 activation promotes Kras-induced and inflammation-induced acinar-to-ductal metaplasia and pancreatic cancer.胰腺 STAT5 的激活促进 Kras 诱导的和炎症诱导的腺泡到导管化生和胰腺癌。
Gut. 2024 Oct 7;73(11):1831-1843. doi: 10.1136/gutjnl-2024-332225.
3
PMN-MDSCs are responsible for immune suppression in anti-PD-1 treated TAP1 defective melanoma.多形核髓系来源抑制细胞(PMN-MDSCs)在抗程序性死亡蛋白1(PD-1)治疗的TAP1缺陷型黑色素瘤中发挥免疫抑制作用。
Clin Transl Oncol. 2025 Jan 18. doi: 10.1007/s12094-024-03840-7.
4
Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer.细胞特异性纳米工程策略,以破坏髓源性抑制细胞的致耐受性信号并增强胰腺癌的抗肿瘤免疫力。
Cancer Immunol Immunother. 2025 Jun 23;74(8):247. doi: 10.1007/s00262-025-04096-y.
5
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception.胰腺腺鳞癌鳞状细胞转化过程中免疫监视功能减弱为癌症拦截提供了新的治疗机会。
J Immunother Cancer. 2025 Jun 23;13(6):e012066. doi: 10.1136/jitc-2025-012066.
6
The Key Role of COA6 in Pancreatic Ductal Adenocarcinoma: Metabolic Reprogramming and Regulation of the Immune Microenvironment.COA6在胰腺导管腺癌中的关键作用:代谢重编程与免疫微环境调节
J Cell Mol Med. 2025 Jul;29(13):e70685. doi: 10.1111/jcmm.70685.
7
Gene Methylation in Tumors with Low CD8 T-Cell Infiltration Drives Positive Prognostic Overall Survival Responses in Pancreatic Ductal Adenocarcinoma.低CD8 T细胞浸润肿瘤中的基因甲基化驱动胰腺导管腺癌的总体生存预后良好。
Int J Mol Sci. 2025 Jun 10;26(12):5567. doi: 10.3390/ijms26125567.
8
CCN1 Enhances Tumor Immunosuppression through Collagen-Mediated Chemokine Secretion in Pancreatic Cancer.CCN1通过胶原蛋白介导的趋化因子分泌增强胰腺癌中的肿瘤免疫抑制作用。
Adv Sci (Weinh). 2025 Jun;12(23):e2500589. doi: 10.1002/advs.202500589. Epub 2025 Apr 27.
9
The prognostic significance of the NMD core factor UPF1 in low-grade glioma.NMD核心因子UPF1在低级别胶质瘤中的预后意义
Sci Rep. 2025 Jul 1;15(1):20574. doi: 10.1038/s41598-025-05711-9.
10
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.李斯特菌疫苗和 T 调节细胞耗竭激活针对早期胰腺上皮内瘤变的免疫并延长小鼠的生存时间。
Gastroenterology. 2014 Jun;146(7):1784-94.e6. doi: 10.1053/j.gastro.2014.02.055. Epub 2014 Mar 6.

本文引用的文献

1
Mitohormesis.线粒体激素。
Cell Metab. 2023 Nov 7;35(11):1872-1886. doi: 10.1016/j.cmet.2023.10.011.
2
Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction.多面线粒体:将线粒体科学从功能和功能障碍的局限中解放出来。
Nat Metab. 2023 Apr;5(4):546-562. doi: 10.1038/s42255-023-00783-1. Epub 2023 Apr 26.
3
Pancreatic cancer: Advances and challenges.胰腺癌:进展与挑战。
Cell. 2023 Apr 13;186(8):1729-1754. doi: 10.1016/j.cell.2023.02.014.
4
Recent advances of mitochondrial complex I inhibitors for cancer therapy: Current status and future perspectives.线粒体复合物 I 抑制剂在癌症治疗中的最新进展:现状与展望。
Eur J Med Chem. 2023 May 5;251:115219. doi: 10.1016/j.ejmech.2023.115219. Epub 2023 Feb 24.
5
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.单细胞 RNA 测序揭示了化疗对人胰腺导管腺癌及其肿瘤微环境的影响。
Nat Commun. 2023 Feb 13;14(1):797. doi: 10.1038/s41467-023-36296-4.
6
The Role of Immunotherapy in Pancreatic Cancer.免疫疗法在胰腺癌中的作用。
Curr Oncol. 2022 Sep 23;29(10):6864-6892. doi: 10.3390/curroncol29100541.
7
A Plate Reader-Based Measurement of the Cellular ROS Production Using Dihydroethidium and MitoSOX.基于微孔板的二氢乙锭和 MitoSOX 检测细胞内 ROS 产生的方法
Methods Mol Biol. 2022;2497:333-337. doi: 10.1007/978-1-0716-2309-1_24.
8
Regulation and functional role of the electron transport chain supercomplexes.电子传递链超级复合物的调控和功能作用。
Biochem Soc Trans. 2021 Dec 17;49(6):2655-2668. doi: 10.1042/BST20210460.
9
The origins and consequences of variants in pancreatic adenosquamous carcinoma.胰腺腺鳞癌变异的起源和后果。
Elife. 2021 Jan 6;10:e62209. doi: 10.7554/eLife.62209.
10
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer.肿瘤衍生的髓系细胞趋化因子与胰腺癌中的 T 细胞排斥
Front Immunol. 2020 Nov 10;11:605619. doi: 10.3389/fimmu.2020.605619. eCollection 2020.